| |
| Must-read payer opinions on new formulary exclusions, oncology coverage, and gene therapy access. |
| To successfully navigate the payer landscape, you need to know what payers are thinking—especially as industry changes are brewing. Precision for Value’s All Access is researched and written by payer experts for market access leaders like you, to deliver quick insider insights that give you an edge for the future. Your free issue of All Access features: |
| • |
Why the Express Scripts 2019 Formulary
Exclusion List Is the Biggest Update Ever. With new disease categories included for the first time, the update is one of the most aggressive in years. |
| • |
Oncology Coverage Policies: How to Help Payers Stay Ahead of the Scientific Curve. With an avalanche of new FDA-approved oncology drugs, how will payers keep up with new agents and expanding indications? |
| • |
Survey Results: The Gene Therapy Revolution, Are Payers Ready? A recent Precision for Value Rapid Pulse™ survey of payers and IDN decision makers reveals current and future challenges of gene therapy. |
| Once you’ve read this free newsletter, specifically curated for busy market access leaders, we believe All Access will be an indispensable reference that informs your winning strategies and tactics. |
 |
|
 |
| Get to know payers better and win market share with this free newsletter |
 |
|
